Laura and Isaac Perlmutter Cancer Center at NYU Langone — New York, New York

Public research footprint of Laura and Isaac Perlmutter Cancer Center at NYU Langone, compiled from the ClinicalTrials.gov public registry.

360

Registered studies

210

Active

Recruiting now

117

Completed

Stopped or withdrawn

Most-studied conditions

Anatomic Stage III Breast Cancer AJCC v8 · Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 · Clinical Stage II Esophageal Adenocarcinoma AJCC v8 · Metastatic Bladder Large Cell Neuroendocrine Carcinoma

Recently updated registry entries

NCT06203600 — Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal… (Recruiting)
NCT05099003 — A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed… (Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Laura and Isaac Perlmutter Cancer Center at NYU Langone?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.